Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 18.2B | 17.2B | 16.1B | 15.4B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 10.6B | 10.3B | 10.0B | 10.2B |
Operating income | 7.6B | 7B | 6.1B | 5.2B |
Non operating interest income | ||||
Income | 254M | — | 92M | 127M |
Expense | 68M | 30M | 8M | 6M |
Other income expense | — | — | — | — |
Pretax income | 7.6B | 7.0B | 6.2B | 5.3B |
Tax provision | 2.2B | 2.2B | 1.9B | 1.6B |
Net income | 5.4B | 4.8B | 4.3B | 3.6B |
Basic EPS | — | 23.8 | 21.2 | 18.2 |
Diluted EPS | — | 23.8 | 21.2 | 18.1 |
Basic average shares | — | 32.9B | 33.1B | 32.6B |
Diluted average shares | — | 33.0B | 33.1B | 32.7B |
EBITDA | 8.5B | 7.9B | 7.2B | 6.2B |
Net income from continuing op. | 7.6B | 7.0B | 6.2B | 5.3B |
Minority interests | -5M | -7M | -16M | 2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |